• SENSEX 75,519.23
    -776.13 (--1.02%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Tata Motors
    613.20 606.20(%)
  • Hindalco Inds.
    608.00 558.00(%)
  • Hind.Aeronautics
    4,205.05 3,045.95(%)
  • Reliance Industr
    1,192.85 1,156.00(%)
  • Mazagon Dock
    2,542.50 995.38(%)
  • Vedanta
    403.50 297.70(%)
  • Interglobe Aviat
    5,150.65 5,187.00(%)
  • Infosys
    1,451.50 1,359.10(%)
  • HDFC Bank
    1,842.20 1,880.00(%)
  • Bajaj Finance
    8,795.75 9,258.95(%)
  • TCS
    3,307.55 3,396.10(%)
  • ICICI Bank
    1,336.40 1,372.50(%)
  • Suzlon Energy
    55.00 37.95(%)
  • Vodafone Idea
    7.85 6.60(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Jio Financial
    222.00 198.60(%)
  • Larsen & Toubro
    3,257.00 3,141.30(%)
  • Angel One
    2,317.80 1,942.00(%)
  • Kalyan Jewellers
    485.80 337.00(%)
  • O N G C
    225.70 215.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ind-Swift Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7927.0
  • ISIN : INE915B01019
91.74 2 (2.58%)
  • As on 04 Apr 2025 (EOD)

  • Today’s Low

    89.00

  • Today’s High

    93.50

  • Open

    89.00

  • Perv Close

    89.43

  • 52W Low

    81.47

  • 52W High

    186.00

Key Indicators

  • P/E(TTM)

    6.04

  • Mar.Cap (₹Cr.)

    542.06

  • Div & Yield %

    0.00

  • Book Value(₹)

    170.51

  • Debt-Equity Ratio

    2.58

  • AGM Date

    03-Apr-2025

  • EPS

    15.18

  • P/E Ratio

    6.04

Financials Ratios

  • Debt-Equity Ratio

    0.61

  • Mar.Cap (₹Cr.)

    542.06

  • RONW (%)

    19.32

  • ROCE (%)

    20.71

Score Board

  • Equity (₹ in Cr.)

    59.09

  • BV (₹)

    170.50

  • Sales( ₹ in Cr.)

    1,227.32

  • NP (in Cr.)

    137.89

  • NP Var(%)

    147.0

  • Div%

    0.0

  • CPS (₹)

    32.40

  • EPS (₹)

    23.30

  • Traded Value (₹ in Lakhs)

    542.12

  • 52 Week High

    186.00

  • 52 Week Low

    81.47

  • Price BSE

    92.0

  • Price NSE

    92.00

  • Market Capital( in Cr.)

    542.12

  • P/C Ratio

    2.80

  • P/E Ratio

    3.90

  • Price Vs.BV

    23.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,227.32 1,151.96 988.09 856.58 751.84 724.43
Excise Duty 1,220.18 1,151.91 987.95 856.02 749.28 724.43
Net Sales 1,227.32 1,151.96 988.09 856.58 751.84 724.43
Other Income 45.31 33.28 42.50 23.13 36.02 47.00
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,272.63 1,185.24 1,030.59 879.71 787.86 771.43
EXPENDITURE :
Raw Materials 1,220.18 1,151.91 987.95 856.02 749.28 724.43
Power & Fuel Cost 1,220.18 1,151.91 987.95 856.02 749.28 724.43
Employee Cost 148.88 132.70 124.62 104.17 100.38 95.59
Other Manufacturing Expenses 23.20 1.75 14.53 1.87 0.62 0.39
Selling & Administrative Expenses 81.00 67.30 65.45 80.26 70.49 57.64
Miscellaneous Expenses 23.20 1.75 14.53 1.87 0.62 0.39
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,081.75 1,079.39 1,020.90 863.59 807.42 795.43
Operating Profit 100.68 111.28 91.64 64.79 59.54 66.23
Interest 51.10 92.17 95.55 100.22 107.48 92.20
Gross Profit 577.47 79.20 8.00 16.12 -19.56 58.93
Depreciation 53.30 57.36 130.97 87.29 90.06 104.05
Profit Before Tax 577.47 79.20 8.00 16.12 -19.56 58.93
Tax 160.89 16.12 4.96 0.69 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.84 23.36 -10.92 9.48 0.82 16.99
Reported Net Profit 418.39 42.47 -5.71 -4.40 -20.79 38.58
Extraordinary Items 577.47 79.20 8.00 16.12 -19.56 58.93
Adjusted Net Profit 418.39 42.47 -5.71 -4.40 -20.79 38.58
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 418.39 42.47 -5.71 -4.40 -20.79 38.58
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 70.81 7.19 -0.97 -0.74 -4.20 8.25
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    40.94%

  • Public Share Holding

    59.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 22,327,507 36.83 22,327,507 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,491,276 4.11 2,491,276 17
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 24,818,783 40.94 24,818,783 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,820,627 3.00 1,820,627 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 554,040 0.91 554,040 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,374,667 3.92 2,374,667 8
2] Non Institution
Bodies Corporate 8,520,466 14.06 8,510,666 163
Clearing Members 129,843 0.21 129,843 19
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 518,873 0.86 518,873 403
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 855,312 1.41 855,312 688
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 13,082,717 21.58 13,082,717 128
Individuals holding nominal share capital up to Rs. 1 lakh 9,815,087 16.19 9,683,737 26,746
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 390,435 0.64 390,435 3
Sub Total 33,425,410 55.14 33,284,260 28,164
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 60,618,860 100.00 60,477,710 28,190

Company Background

Ind-Swift Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ind-Swift Laboratories Ltd
  • BSE Code : 7927.0
  • ISIN : INE915B01019

  • Incorporation Year

    1995

  • Registered Office

    SCO 850 Shivalik Enclave
    NAC Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

    91-0172-5061850/2730920

  • FAX

    91-0172-2730504/2736294

  • Chairman

    N R Munjal

  • Managing Director

    N R Munjal

  • Company Secretary

    Pradeep Verma

  • Auditor

    Avishkar Singhal & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    205/208,
    Anarkali Market,Jhandewalan Extn
    Mumbai - New Delhi - 110055

Ind-Swift Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ind-Swift Labs. 91.75 1,272.63 1,227.32 1.50 20.55
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92